Although the overexpressed PFKFB3/4 isoenzymes are considered oncogenic, mantle cell lymphoma, ovarian and pancreatic adenocarcinoma data sets have revealed that patients with low expression of PFKFB3 enzyme have significantly worse survival rates in comparison to the ones with high expression (Table 1). Here, PFKFB3 is linked to mantle cell lymphoma.